Qingyang Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qingyang Liu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Hui Wang
Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing 210023, China
2 shared publicationsQian Wang
College of International Education, Nanjing University of Chinese Medicine, Nanjing 210023, China
2 shared publications- Qisheng Wang
College of Pharmacy Nanjing University of Chinese Medicine Nanjing China
2 shared publications Shengfeng Lu
Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing 210023, China
2 shared publicationsXinru Mu
Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing 210023, China
2 shared publicationsYongwei Jiang
Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing 210023, China
2 shared publications
Latest Publications
- 25 September 2022
- Published by Elsevier in Phytomedicine
- Vol. 108, 154475
Compound 511 ameliorates MRSA-induced lung injury by attenuating morphine-induced immunosuppression in mice via PI3K/AKT/mTOR pathway
- 25 September 2022
- Published by Elsevier in Phytomedicine
- Vol. 108, 154475
Compound 511 ameliorates MRSA-induced lung injury by attenuating morphine-induced immunosuppression in mice via PI3K/AKT/mTOR pathway
- 23 September 2022
- Published by Elsevier in Phytomedicine
- Vol. 108, 154467
Normalization of the H3K9me2/H3K14ac-ΔFosB pathway in the nucleus accumbens underlying the reversal of morphine-induced behavioural and synaptic plasticity by Compound 511
- 23 September 2022
- Published by Elsevier in Phytomedicine
- Vol. 108, 154467
Normalization of the H3K9me2/H3K14ac-ΔFosB pathway in the nucleus accumbens underlying the reversal of morphine-induced behavioural and synaptic plasticity by Compound 511